<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: FTSE 100 soars on vaccine hopes	</title>
	<atom:link href="https://ukinvestor.foxrobinson.com/ftse-100-soars-on-vaccine-hopes/feed/" rel="self" type="application/rss+xml" />
	<link>https://ukinvestor.foxrobinson.com/ftse-100-soars-on-vaccine-hopes/</link>
	<description></description>
	<lastBuildDate>Wed, 20 May 2020 18:56:05 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.2</generator>
	<item>
		<title>
		By: Dow Jones keen to rebound after Moderna vaccine doubts - UK Investor Magazine		</title>
		<link>https://ukinvestor.foxrobinson.com/ftse-100-soars-on-vaccine-hopes/#comment-15262</link>

		<dc:creator><![CDATA[Dow Jones keen to rebound after Moderna vaccine doubts - UK Investor Magazine]]></dc:creator>
		<pubDate>Wed, 20 May 2020 18:56:05 +0000</pubDate>
		<guid isPermaLink="false">https://ukinvestor.foxrobinson.com/?p=28900#comment-15262</guid>

					<description><![CDATA[[&#8230;] The Dow Jones enjoyed a bright start to the session, rallying 400 points to 24,600 points. This was led by some &#8216;solid&#8217; earnings, lingering vaccine optimism and hopes of further Fed stimulus in coming weeks, and came despite what many pundits described as the &#8216;Moderna (NASDAQ:MRNA) shuffle&#8217; &#8211; the fluctuating price of the stock since it published vaccine test results on Monday. [&#8230;]]]></description>
			<content:encoded><![CDATA[<p>[&#8230;] The Dow Jones enjoyed a bright start to the session, rallying 400 points to 24,600 points. This was led by some &#8216;solid&#8217; earnings, lingering vaccine optimism and hopes of further Fed stimulus in coming weeks, and came despite what many pundits described as the &#8216;Moderna (NASDAQ:MRNA) shuffle&#8217; &#8211; the fluctuating price of the stock since it published vaccine test results on Monday. [&#8230;]</p>
]]></content:encoded>
		
			</item>
	</channel>
</rss>
